Licensing Agreement With Viridian Therapeutics For "Veligrotug" And "Vrdn-003" In Treatment Of Thyroid Eye Disease

Kissei Pharmaceutical

30/07/2025 09:01

July 30 (Reuters) - Kissei Pharmaceutical Co Ltd 4547.T:

KISSEI PHARMACEUTICAL CO LTD: LICENSING AGREEMENT WITH VIRIDIAN THERAPEUTICS FOR "VELIGROTUG" AND "VRDN-003" IN TREATMENT OF THYROID EYE DISEASE

Source text: ID:nTSsd7fd2d

Further company coverage: 4547.T

 (Reporting by Tokyo Newsroom)

 ((+81345201189;))